- Joined
- Nov 26, 2013
- Messages
- 1,352
- Reaction score
- 193
So Kaplan immuno lists several risks of passive immunotherapy as below:
1. Introduction of antibodies from other species can generate IgE antibodies which may cause systemic anaphylaxis.
--> Why particularily IgE? I get that IgE is related to anaphylaxis with mast cells in hypersensitivity type I rxn and in order to get IgE, you would need TH2 cell's to stimulate B cells.
So is this saying that introduction of antibodies may stimulate TH2 and cause anaphylaxis just like there are million things out there that can lead to anaphylaxis to different people?
So this is probably beyond step 1, but we still don't know why certain people get anaphylaxis, right? Is this mainly related to genetics?
2. Introduction of antibodies from other species can generate IgG or IgM anti-isotype antibodies, which form complement-activating immune complexes, which can lead to type III hypersensitivity reaction
--> So this is through MHC Class II pathway where the foreign antibotides will be processed by APC (antigen presenting cells) which stimulates TH0 to become TH2, which stimulates B cells to produce IgG or IgM anti-isotype antibodies, did I get this right?
3. Introduction of antibodies from humans can elicit responses against minor immunoglobulin polymorphisms or allotypes.
--> How is this much different from #2?
Lastly, introduction of antibodies will not elicit cytotoxic T cells response which has to do with MHC class 1 since antibodies won't be residing inside cells where it can be processed by TAP and do all that MHC class 1 thing, right?
Sorry for bombarding with so many questions, but immuno is really a headache. It's never intuitive.
1. Introduction of antibodies from other species can generate IgE antibodies which may cause systemic anaphylaxis.
--> Why particularily IgE? I get that IgE is related to anaphylaxis with mast cells in hypersensitivity type I rxn and in order to get IgE, you would need TH2 cell's to stimulate B cells.
So is this saying that introduction of antibodies may stimulate TH2 and cause anaphylaxis just like there are million things out there that can lead to anaphylaxis to different people?
So this is probably beyond step 1, but we still don't know why certain people get anaphylaxis, right? Is this mainly related to genetics?
2. Introduction of antibodies from other species can generate IgG or IgM anti-isotype antibodies, which form complement-activating immune complexes, which can lead to type III hypersensitivity reaction
--> So this is through MHC Class II pathway where the foreign antibotides will be processed by APC (antigen presenting cells) which stimulates TH0 to become TH2, which stimulates B cells to produce IgG or IgM anti-isotype antibodies, did I get this right?
3. Introduction of antibodies from humans can elicit responses against minor immunoglobulin polymorphisms or allotypes.
--> How is this much different from #2?
Lastly, introduction of antibodies will not elicit cytotoxic T cells response which has to do with MHC class 1 since antibodies won't be residing inside cells where it can be processed by TAP and do all that MHC class 1 thing, right?
Sorry for bombarding with so many questions, but immuno is really a headache. It's never intuitive.
Last edited: